Study explains mechanisms behind glioblastoma influence on the immune system
Glioblastomas exert an influence on the microglia, immune cells of the brain, which causes them to stimulate cancer growth rather than attacking it. In a study published in the journal Nature Immunology, an international research team led from Sweden's Karolinska Institutet now explains the molecular mechanisms behind this action.
Glioblastomas are one of the most malignant forms of brain tumour and are difficult to surgically remove because the tumour cells invade the surrounding healthy brain tissue. Glioblastomas also affect the microglia – immune cells of the brain – in such a way that they stimulate the tumour cells instead of attacking them.
The multi-national research group has previously shown that pro-inflammatory activation of microglia is controlled by a group of enzymes called caspases. In the present study, they sought to examine if the way the cancer cells affect microglia also includes similar mechanism. By cultivating microglia and glioblastoma cells together, the researchers were able to show that the cancer cells inhibit caspase-3 activity in the microglia.
"We show that it's the same inhibition of caspase-3 that causes the microglia to stimulate the tumour cells instead of attacking them," says Bertrand Joseph, Principal Investigator at Karolinska Institutet's Department of Oncology-Pathology. "When we removed caspase-3 from the microglia in a glioblastoma mouse model, the tumours grew more quickly."
According to the study authors, their results demonstrate that the glioma cells use a nitric oxide-dependent mechanism to force microglia to modify caspase-3 to form a tumour-stimulating form of these cells.
"Two things surprised us," says Bertrand Joseph. "First and foremost, that affecting the signalling mechanism between glioblastoma cells and microglia that we discovered has such a major effect on tumour growth. Secondly, that basal caspase-3 activity, which is often considered to be an absence of activity, fulfills essential function in regulating microglia cell behavior."
The lead authors of the study are Xianli Shen and Miguel Burguillos. Researchers from at the Universidad de Sevilla, Spain, Stockholm University, Sweden, and Yale University, USA, and others also contributed to this study. The research was financed with grants from, amongst others, the Swedish Research Council, the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Swedish Brain Fund, StratCan, StratNeuro, and the ALF agreement with Stockholm County Council.
Publication: 'Glioma-induced caspase-3 inhibition in microglia promotes a tumor-supportive phenotype', Xianli Shen, Miguel A. Burguillos, Ahmed M. Osman, Jeroen Frijhoff, Alejandro Carrillo-Jiménez, Sachie Kanatani, Martin Augsten, Dalel Saidi, Johanna Rodhe, Edel Kavanagh, Anthony Rongvaux, Vilma Rraklli, Ulrika Nyman, Johan Holmberg, Arne Östman, Richard A. Flavell, Antonio Barragan, Jose Luis Venero, Klas Blomgren and Bertrand Joseph, Nature Immunology, online 12 September 2016, 2016, doi: 10.1038/ni.3545.
To contact the Press Office and download images: ki.se/pressroom
Karolinska Institutet — a medical university: ki.se/english
KI Press Office